McKesson stock holds near analyst targets as cybersecurity risk draws attention

Published on 09/18/2026 at 13:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

McKesson stock closed at USD 879.28 on September 17, 2026, leaving the shares about 10.4 percent below an average analyst target of USD 980.73. A recent disclosure of a cybersecurity incident in oncology and medical-surgical units adds a risk dimension for investors.

Mitarbeiter sortieren unbeschriftete Pakete in einem großen Pharma-Logistiklager mit Regalen — Fotorealistisches Bild zeigt McKesson Corporation ISIN US58155Q1031 als Pharmagroßhändler in modernem Distributionslager mit vielen Mitarbeitern, Illustration mit AI erstellt.

McKesson Corporation stock (ISIN US58155Q1031) closed at USD 879.28 on the New York Stock Exchange on September 17, 2026, putting the shares roughly 10.4 percent below an average analyst price target of USD 980.73 highlighted in recent market data overviews. As of mid-September 2026, investors are weighing this valuation gap against a newly disclosed cybersecurity incident affecting parts of McKesson's customer base.

Price levels and distance to targets

According to recent quote data compiled on September 17, 2026, McKesson stock ended regular trading at USD 879.28 on the NYSE, down USD 8.01 or 0.9 percent from the prior close, with extended trading later nudging the price to USD 880.92 in the evening session. The same overview cites a market capitalization of about USD 102.6 billion for McKesson, underscoring the company's status as one of the larger names in medical distribution and healthcare services.MarketBeat

In a separate market snapshot as of September 16, 2026, McKesson stock was quoted at USD 889.78 on the NYSE, down USD 9.78 or 1.09 percent from a previous close of USD 899.56. The same data set shows a 52-week range for McKesson between USD 687.68 and USD 999.00, meaning the September 16, 2026 close left the shares about 12.0 percent above the 52-week low but roughly 11.0 percent below the 52-week high.AD HOC NEWS

Analyst target spectrum and valuation context

Per an analyst overview referenced in the same September 16, 2026 market data, the price targets for McKesson stock span a low estimate of USD 845.00, an average of USD 980.73 and a high of USD 1,065.00. With the stock around USD 889.78 on that date, the shares traded about 10.2 percent below the average target and roughly 16.5 percent under the high estimate, pointing to potential upside implied by the analyst community if McKesson delivers on its earnings trajectory.AD HOC NEWS

The same overview highlights that McKesson's one-year share price return of 28.71 percent comfortably exceeded the S&P 500 index's 13.76 percent gain over the comparable period as of September 16, 2026. For investors, this quantified outperformance reinforces McKesson's profile as a healthcare stock that has recently beaten the broader US equity benchmark by around 15 percentage points over twelve months.AD HOC NEWS

Cybersecurity incident adds a risk angle

Beyond valuation metrics, McKesson has recently had to address a cybersecurity incident involving third-party applications supporting its Oncology & Multispecialty and Medical-Surgical business units. According to an incident timeline compiled from public disclosures, McKesson reported in an SEC filing that unauthorized access to certain third-party environments was detected on August 25, 2026, followed by data exfiltration affecting a subset of customers in these segments.ZeroHour

The same summary notes that the threat actor group ShinyHunters claimed responsibility, alleging that it used vishing calls to obtain employee credentials, hijacked Okta single sign-on accounts and then extracted roughly a terabyte of data from Salesforce and Snowflake environments over four days. The group further claimed access to about 284 million database rows including personal and medical-related information, and demanded more than USD 55 million from McKesson, though these specific claims have not been independently verified.ZeroHour

For shareholders, the quantified scale of the alleged data set in the threat actor's narrative, combined with the company's own acknowledgment of unauthorized access to third-party applications, underlines cybersecurity and compliance risk as a material consideration alongside traditional financial metrics. While no immediate revision to guidance has been reported in the available sources, any future disclosure on remediation costs, potential fines or customer churn could influence both earnings expectations and how close the stock moves toward or away from the current analyst target band.

Stock level and investor takeaway

As of the last completed regular session on September 17, 2026, McKesson stock stands at USD 879.28 on the NYSE in USD terms, with the shares trading between roughly 12 percent above the 52-week low of USD 687.68 and about 12 percent below the recent 52-week high of USD 999.00 based on mid-September market data. This positioning, combined with an average analyst target of USD 980.73 and a high target of USD 1,065.00 as of September 16, 2026, keeps McKesson stock in a valuation zone where both upside potential and the emerging cybersecurity risk profile are likely to shape investor decisions over the coming months.